ClinConnect ClinConnect Logo
Search / Trial NCT07104006

Smoking Cessation Intervention for Young Adults Using MTM: A Randomized Controlled Trial

Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Jul 29, 2025

Trial Information

Current as of November 12, 2025

Not yet recruiting

Keywords

Smoking Cessation Intervention Multi Theory Model (Mtm) Of Behavior Change Young Adults Randomized Controlled Trial (Rct)

ClinConnect Summary

This clinical trial is testing a new program designed to help young adults aged 18 to 29 quit smoking cigarettes. The program uses a special approach called the Multi-Theory Model (MTM), which focuses on building confidence, managing emotions, and changing both behavior and surroundings to support quitting. The researchers want to see if this approach helps more people stop smoking compared to a standard education program that simply shares information about the risks of smoking and available quitting tools.

If you join the study, you’ll be randomly placed into one of two groups. One group will attend four weekly online sessions that include interactive activities focused on motivation, emotional support, and practical strategies for quitting. The other group will attend four online sessions that provide information about smoking risks and quitting options. You’ll be asked to complete surveys about your smoking habits and feelings before the program starts, right after it ends, and again after 12 weeks. There’s also an option to confirm quitting by a simple breath test. This study is done entirely online, making it easy to participate from home. It’s important to note that this trial is for cigarette smokers who live in the U.S., smoke daily, and are not using other tobacco products or involved in other quitting programs. The goal is to find better ways to help young adults successfully quit smoking and stay smoke-free for good.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 18-29 years
  • Current smoker (defined as having smoked at least one cigarette daily over the past 7 days)
  • Resident of the United States
  • Able to read and understand English
  • Exclusion Criteria:
  • Use of non-cigarette tobacco products (e.g., vaping, smokeless tobacco)
  • Participation in any other smoking cessation program
  • Pregnant or planning to become pregnant during the study period
  • Dual or poly-substance users, including alcohol or illicit drugs.

About University Of Nevada, Las Vegas

The University of Nevada, Las Vegas (UNLV) is a prominent research institution committed to advancing healthcare through innovative clinical trials. With a focus on multidisciplinary collaboration, UNLV engages in rigorous scientific inquiry to explore new treatments and interventions that address pressing health challenges. The university's dedicated faculty and state-of-the-art facilities foster an environment conducive to cutting-edge research, ensuring the highest standards of ethical practice and patient care. Through its clinical trials, UNLV aims to contribute to the body of medical knowledge while improving health outcomes for diverse populations.

Locations

Las Vegas, Nevada, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported